Drawing on the combined resources, experience and record of our top-ranked health law and antitrust practices, McDermott’s health antitrust lawyers provide clients with sophisticated, practical legal counsel where one of the most highly regulated, rapidly evolving industries meets one of the most complex area of law. We help hospitals, health systems and other providers identify antitrust risks and implement solutions that achieve business objectives and improve the delivery of services.
We regularly advise clients regarding the antitrust implications of provider mergers, acquisitions, joint ventures and joint operating agreements and defend those transactions before state and federal antitrust enforcement agencies. We assist clients in the development of clinical integration programs, accountable care organizations (ACOs) and other provider managed care contracting networks such as IPAs and PHOs, and the structuring of co-marketing arrangements, Medicaid collaboratives, trade associations and joint-purchasing arrangements.
We provide legal counsel on a broad range of day-to-day operations that may expose healthcare organizations to antitrust risks, including managed care contracts, economic credentialing, physician conflicts of interest, exclusive services agreements, purchase and use of discounted pharmaceuticals under the Non-Profit Institutions Act, integrated delivery systems, vertical integration and participation in information exchanges.
Our primary goal is to help clients avoid antitrust investigations and litigation. In so doing, we regularly develop and implement antitrust compliance plans, protocols, firewalls and training on appropriate policies and procedures. We also help clients identify and mount potential defenses and immunities, such as certificates of public advantage and joint actions to influence government policy (Noerr immunity). When investigations, civil litigation or class actions arise, our health antitrust litigators draw on their prior successes to mount a solid defense in court and before regulatory agencies.
We provide clients with sophisticated, practical legal counsel at the intersection where one of the most highly regulated, rapidly evolving industries meets one of the most complex area of law.
Bloomberg Law / October 7, 2019
Antitrust M&A Snapshot / AUGUST 2019
On the Subject / June 20, 2019
Special Report / June 2019
On the Subject / May 23, 2019
Nashville, TN / Speaking Engagements / May 2, 2019
Nashville, TN / Speaking Engagements / May 1-3, 2019
Boston, MA / Speaking Engagements / June 25, 2019
United Kingdom / Special Report / March 25, 2019
San Francisco, CA / Speaking Engagements / March 12-13, 2019
Philadelphia, PA / Speaking Engagements / March 12-13, 2019
Webinar / Speaking Engagements / April 2017
Webinar / December 12, 18
On the Subject / November 28, 2018
Special Report / June 2018
Arlington, Virginia / Speaking Engagements / May 17-18, 2018
Antitrust M&A Snapshot / March 2018
Webinar / Speaking Engagements / July 26, 2017
Corporate Law & Governance Newsletter / March 2017
Webinar / McDermott Event / February 28, 2017
On the Subject / November 2, 2016
On the Subject / October 25, 2016
On the Subject / October 13, 2016
On the Subject / September 28, 2016
On the Subject / May 17, 2016
Video / May 12, 2016
AHLA Weekly / April 8, 2016
On the Subject / December 23, 2015
On the Subject / March 3, 2015
On the Subject / March 2, 2015
On the Subject / February 27, 2015
/ December 2014
/ October 2014
/ July 2014
On the Subject / May 20, 2014
On the Subject / March 25, 2014
International Law Office Newsletter, Germany / February 19, 2014
Yet another Health Reform and Seizure of Retiring Doctors' Practices
On the Subject / February 14, 2014
1
2
3
4
5
6
7
... 7
New York / Press Releases / October 24, 2019
Chicago / Accolades & Rankings / August 16, 2019
2020 Best Lawyers In America Recognizes Over 150 McDermott Lawyers
Law360 / November 30, 2018
Mergers & Acquisitions / November 30, 2018
M&A Wrap: TPG, Sterling Partners, Q-Centrix, Warburg Pincus, Crescent
Accolades & Rankings / July 10, 2018
McDermott Partners Veleka R. Peeples-Dyer and Vernessa Pollard Recognized in Savoy Magazine’...
Comté d’Orange / Global Legal Chronicle / April 21, 2017
Otsuka Pharmaceutical Co., Ltd.’s $250 Million Acquisition of Neurovance, Inc
Dallas / Finance Digest / April 10, 2017
Washington, DC / Medicare Advantage News / March 2, 2017
Fearing Lower Risk-Adjusted Pay, MA Plans Want CMS to Go ‘Back to ...
1
2
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.